Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 1 Trials

Grand Rapids, Michigan

Phase 1 colorectal cancer trials in Grand Rapids, MI

32 Phase 1 colorectal cancer studies are recruiting participants at sites in Grand Rapids as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.

Call (888) 415-5976
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Grand Rapids at a glance

  • 32 studies are recruiting at a site in Grand Rapids.
  • By phase: Phase 1 (22), Phase 1/2 (10).
  • By sponsor: industry (31), university, hospital or other (1).
  • Most recent update to one of these records: November 17, 2026.

Studies recruiting in Grand Rapids

Basic details from each study's public record (the 30 most recently updated of 32). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Institut de Recherches Internationales Servier
    Study site
    South Texas Accelerated Research Therapeutics (START) Midwest
    Registry record
    NCT05786924 · updated
  2. A Phase 1/2 Study of IAM1363 in HER2 Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Study site
    START - Midwest Cancer Research Center
    Registry record
    NCT06253871 · updated
  3. A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Aktis Oncology, Inc.
    Study site
    BAMF Health
    Registry record
    NCT07020117 · updated
  4. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    START Midwest
    Registry record
    NCT07488676 · updated
  5. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Vividion Therapeutics, Inc.
    Study site
    START Midwest
    Registry record
    NCT06004245 · updated
  6. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pliant Therapeutics, Inc.
    Study site
    South Texas Accelerated Research Therapeutics (START)
    Registry record
    NCT06270706 · updated
  7. A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study site
    START Midwest, LLC
    Registry record
    NCT07318805 · updated
  8. A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    South Texas Accelerated Research Therapeutics (START) Midwest
    Registry record
    NCT06400472 · updated
  9. A Study of LY4257496 in Participants With Cancer (OMNIRAY)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    BAMF Health Inc.
    Registry record
    NCT07114601 · updated
  10. A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    BAMF Health Inc.
    Registry record
    NCT07213791 · updated
  11. A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Start Midwest
    Registry record
    NCT06663319 · updated
  12. A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    START Midwest
    Registry record
    NCT06720987 · updated
  13. A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Relay Therapeutics, Inc.
    Study site
    START Midwest, LLC
    Registry record
    NCT07584226 · updated
  14. A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Inc
    Study site
    START Midwest
    Registry record
    NCT07094204 · updated
  15. A Study of MGC026 in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    MacroGenics
    Study site
    START Midwest
    Registry record
    NCT06242470 · updated
  16. A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    START Midwest /ID# 283487
    Registry record
    NCT07807956 · updated
  17. AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Avacta Life Sciences Ltd
    Study site
    START Midwest
    Registry record
    NCT07454642 · updated
  18. 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Radiopharm Theranostics, Ltd
    Study site
    BAMF Health
    Registry record
    NCT07189871 · updated
  19. A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    ALX Oncology Inc.
    Study site
    ALX Center 3
    Registry record
    NCT07085091 · updated
  20. Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    START Midwest
    Registry record
    NCT06128551 · updated
  21. Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    START Midwest
    Registry record
    NCT07349537 · updated
  22. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    EvolveImmune United, Inc
    Study site
    START Midwest
    Registry record
    NCT07217171 · updated
  23. Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

    • Phase 1
    • Ages 12 to 85
    • All sexes
    Sponsor
    Inhibrx Biosciences, Inc
    Study site
    START Midwest Michigan, PC
    Registry record
    NCT03715933 · updated
  24. A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Cartography Biosciences
    Study site
    START Midwest
    Registry record
    NCT07321106 · updated
  25. Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

    • Phase 1
    • Ages 18 to 100
    • All sexes
    Sponsor
    Novartis Pharmaceuticals
    Study site
    BAMF Health
    Registry record
    NCT06562192 · updated
  26. A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Seagen, a wholly owned subsidiary of Pfizer
    Study site
    START Midwest
    Registry record
    NCT06131840 · updated
  27. A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Study site
    START Midwest
    Registry record
    NCT07079631 · updated
  28. Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    START Midwest /ID# 248685
    Registry record
    NCT05005403 · updated
  29. A Study of MGC028 in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    MacroGenics
    Study site
    South Texas Accelerated Research Therapeutics (START) Midwest
    Registry record
    NCT06723236 · updated
  30. Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Tasca Therapeutics
    Study site
    START Midwest
    Registry record
    NCT07030257 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Grand Rapids, MI on ClinicalTrials.gov.

Ask about studies near Grand Rapids

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Michigan

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 415-5976

or send a short form

How should we reach you?

Call